Table 1.
Characteristics | n (%) |
---|---|
Total | 93 (100) |
Age group | |
35-44 | 6 (6) |
45-54 | 16 (17) |
55-64 | 46 (50) |
65 and above | 25 (27) |
Gender | |
Males | 89 (96) |
Females | 4 (4) |
Cancer site | |
Larynx | 19 (20) |
Hypopharynx | 20 (22) |
Oropharynx | 54 (58) |
Stage of primary tumor | |
T1 | 6 (6) |
T2 | 27 (29) |
T3 | 48 (52) |
T4 | 12 (13) |
Nodal stage | |
N0 | 26 (28) |
N1 | 29 (31) |
N2a | 36 (38) |
N3 | 2 (2) |
Dose of chemotherapy | |
40 mg/m2 weekly | 34 (37) |
100 mg/m2 weekly | 29 (31) |
Carboplatin | 30 (32) |
Type of radiotherapy | |
69.3 Gy/33 fractions | 63 (68) |
70 Gy/35 fractions | 29 (32) |
#Fractions of radiotherapy. CDDP=Cisplatin